SafeOp Patient Interface, REF: AIX11240, part of SafeOp 3: Neural Informatix System Recall
SafeOp Patient Interface, REF: AIX11240, part of SafeOp 3: Neural Informatix System
FDA recall Class II
Ongoing
FDA lists this Class II recall for SafeOp Patient Interface, REF: AIX11240, part of SafeOp 3: Neural Informatix System. Review the affected identifiers, reported reason and manufacturer instructions below.
Recall at a glance
- Recall number
- Z-2793-2026
- Recall classification
- Class II
- Enforcement status
- Ongoing
- Initiation date
- May 13, 2026
- FDA report date
- Jul 29, 2026
- Quantity in commerce
- 3
- Distribution
- See key details
- FDA cause
- Software Design Change
What is being recalled?
SafeOp Patient Interface, REF: AIX11240, part of SafeOp 3: Neural Informatix System
Affected model & UDI checker
Search the exact identifiers published for Z-2793-2026.
The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.
Affected products
| Model / catalog number | Product | Lot scope reported | UDI / GTIN |
|---|---|---|---|
| AIX11240 | SafeOp Patient Interface, REF: AIX11240, part of SafeOp 3: Neural Informatix System | Check source notice | Not specified |
| Not specified | SafeOp Patient Interface, REF: AIX11240, part of SafeOp 3: Neural Informatix System | Check source notice | 00190376517506 |
FDA code information
UDI-DI: 00190376517506. System Set ID/Patient Interface Serial Number: 2007716/ DG106225, 2005498/ DG106220, 2005490/ DG106230
Why was this product recalled?
Intraoperative neuromonitoring device, due to a software issue, may experience loss or interruption of triggered electromyography (tEMG) functionality during use, displaying as system faults, loss of communication between the Patient Interface and Tablet, and prompts requiring system reboot; may result in increased operative time and surgical plan change.
These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.
What actions did Alphatec Spine, Inc. take?
On 5/13/2026, recall notices were emailed to customers who were advised of the following: 1) Recalling firm has provided replacement SafeOp 3 Systems. 2) Abstain from using affected devices and return to recalling firm. 3) Share this notice within your organization or any organization where the affected device(s) has(have) been transferred. 4) Fill out the last page of this letter to confirm that you have read this notification and have taken all necessary actions, as described in this notification. If you have any questions/concerns or require assistance with the recall, please e-mail QMSCompliance@atecspine.com or call 1-800-922-1356.
Read the manufacturer action recorded by FDARecall timeline
Recall initiated by firm
FDA notice posted
FDA classification recorded
FDA enforcement report date
Related FDA submissions
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Alphatec Spine, Inc. | 510(k) clearance | Jan 11, 2026 | FDA |
FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.
Source and update history
- FDA recall notice Z-2793-2026
- openFDA enforcement record · Source release Nov 11, 2026 · Retrieved Nov 21, 2026
- openFDA device recall record · Source release Nov 19, 2026 · Retrieved Nov 21, 2026
- FDA enforcement data
First stored snapshot of this source.
- FDA device-recall notice
First stored snapshot of this source.
The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.
Our data sources and methodology
